Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Net Sales 61.41 72.32 79.15 70.61 72.75
Total Expenditure 38.24 43.67 52.26 48.68 46.33
Operating Profit 23.17 28.64 26.89 21.93 26.42
Other Income 0.73 1.74 1.77 2.58 0.94
Interest 0.04 0.02 0.02 0.01 0.01
Depreciation 2.12 2.16 2.22 2.44 2.27
Exceptional Items 0 0 0 0 0
Profit Before Tax 21.73 28.21 26.42 22.07 25.09
Tax 6.41 8.07 6.1 6.83 6.54
Profit After Tax 15.32 20.13 20.32 15.24 18.55
Adjusted EPS (Rs) 1.37 1.8 1.82 1.36 1.66

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 43.65 43.84 47.2 75.85 98.43
Adjustment 6.31 8.84 6.71 3.21 3.47
Changes in Assets & Liabilities -18.85 -21.46 -6.17 -20.38 9.12
Tax Paid -10.05 -8.64 -12.37 -12.7 -26.83
Operating Cash Flow 21.05 22.59 35.37 45.98 84.19
Investing Cash Flow -54.84 -22.06 -1.91 -24.94 -69.91
Financing Cash Flow 33.54 -0.61 -33.47 -18.56 -15.45
Net Cash Flow -0.24 -0.08 0 2.48 -1.16

Investors Details

PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Public 22.16 22.23 21.22 20.5 22.84
mukund madhusudan kabra 1.62 1.62 1.63 1.63 1.63
pradip bhailal shah 1.82 1.91 1.91 1.91 1.91
sri sri ravi shankar trus... 1.05 1.05 1.05 1.05 1.05
iepf 0.07 0.08 0.08 0.08 0.08
orbimed asia iii mauritiu... 2.2 2.2 2.2 2.2 2.2
orbimed asia iii mauritiu... 2.2 2.2 2.2 2.2 2.2
orbimed asia iii mauritiu... 2.2 2.2 2.2 2.2 2.2
llp 0 0 0 0 1.44
PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
FII/DII 19.71 22.33 23.39 24.11 24.86
hdfc small cap fund 6.9 5.81 5.68 5.08 4.39
orbimed asia iii mauritiu... 9.9 9.9 9.89 9.89 9.89
orbimed asia iii mauritiu... 9.9 9.9 9.89 9.89 9.89
reliance capital trustee ... 1.32 0 0 0 0
nalanda india equity fund... 0 4.75 4.74 4.74 4.74
uti - hybrid equity fund 0 0 0 1.64 1.58
icici prudential esg fund... 0 0 0 0 2.14

Advanced Enzyme Stock Price Analysis and Quick Research Report. Is Advanced Enzyme an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Advanced Enzyme and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 84.192 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Advanced Enzyme has a Debt to Equity ratio of 0.0021 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Advanced Enzyme , the EPS growth was 22.4746598836089 % which is good for the company.
     
  • Operating profit margin: It determines a companys potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Advanced Enzyme has OPM of 35.5444786628709 % which is a good sign for profitability.
     
  • ROE: Advanced Enzyme have a average ROE of 17.7595710412853 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholders fund is used for generating profits.
Brief about Advanced Enzyme

Reach out

Find us at the office

Exel- Frazzitta street no. 61, 44925 Kingston, Norfolk Island

Give us a ring

Jovanny Boeding
+23 274 947 142
Mon - Fri, 10:00-21:00

Tell us about you